Ahn-Gook Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.
January 08, 2021 at 09:11 am IST
Share
Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:A001540) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,000 million worth of its shares pursuant to a contract with Small and Medium Business Bank. The purpose of the program is to stabilize stock price. The program will expire on January 7, 2022. As of January 7, 2021, the company had 1,322,067 shares in treasury within scope available for dividend and had 209,453 shares in treasury through other repurchases.
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.